BiomedicalPublications

Hereditary Cancer in Clinical Practice

BioMed Central·Poland·ISSN 1731-2302

Open accessIn DOAJFee waivers availableMedicine

Cost to publish

$2,690

Open-access article processing charge, list price.

Time to publication

18 wks

Broadly typical for the field.

h-index

42

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

2.4

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Hereditary Cancer in Clinical Practice is listed at $2,690. The publisher also lists 2,290 EUR, 1,990 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Hereditary Cancer in Clinical Practice, as recorded by OpenAlex for each year. The fee has risen 8% since 2019, from $2,490 to $2,690.

$0$1.3k$2.7k2019: $2,49020192020: $2,49020202021: $2,49020212022: $2,69020222023: $2,49020232024: $2,59020242025: $2,6902025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelOpen peer review (policy)
LicenceCC BY, CC0
Author keeps copyrightYes
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredOpen peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Hereditary Cancer in Clinical Practice publishes most, derived from the topics assigned to its indexed articles.

BRCA gene mutations in cancerGenetic factors in colorectal cancerColorectal Cancer Screening and DetectionCancer Genomics and DiagnosticsGenomics and Rare DiseasesDNA Repair MechanismsColorectal Cancer Treatments and StudiesOvarian cancer diagnosis and treatmentMultiple and Secondary Primary CancersBreast Cancer Treatment Studies

Publication record

Indexed articles844
Total citations8,000
i10-index242
Most recent indexed article2026
Open access since2003
All ISSNs1731-2302, 1897-4287

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.